Language

News topic

Start: 2025-01

All current shortage notices related to Start: 2025-01, structured by product, country, active ingredient and reporting period.

13 notices

← All shortages

Belgium

Concerta 54 mg (PI Pharma) tabl. prol.-rel. 30

Active ingredient: Methylphenidate Hydrochloride

View notice details →
Germany

Quetiapin beta 300 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin beta 200 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin beta 150 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin - 1 A Pharma 400 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Belgium

Wegovy 2.4 mg (Abacus Medicine) inj. opl. s.c. voorgev. pen 3 ml FlexTouch

Active ingredient: Semaglutide

View notice details →
Germany

Quetiapin AL 300 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin AL 150 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin Heumann retard 50 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin Heumann retard 400 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin Heumann retard 300 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin Heumann retard 200 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →
Germany

Quetiapin Heumann retard 150 mg Retardtabletten

Active ingredient: Quetiapinfumarat (Ph.Eur.)

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.